Latest news
25 items- INSIDERSEC Form 4 filed by Kullback William J4 - Telesis Bio Inc. (0001850079) (Issuer)
- INSIDERSEC Form 3 filed by new insider Kullback William J3 - Telesis Bio Inc. (0001850079) (Issuer)
- SECCodex DNA Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Telesis Bio Inc. (0001850079) (Filer)
- SECSEC Form 10-Q filed by Codex DNA Inc.10-Q - Telesis Bio Inc. (0001850079) (Filer)
- SECCodex DNA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Telesis Bio Inc. (0001850079) (Filer)
- SECCodex DNA Inc. filed SEC Form 8-K: Events That Accelerate or Increase a Direct Financial Obligation8-K - Telesis Bio Inc. (0001850079) (Filer)
- INSIDERHerrema Gregory J. was granted 153,191 shares (SEC Form 4)4 - Telesis Bio Inc. (0001850079) (Issuer)
- INSIDERSEC Form 3 filed by new insider Herrema Gregory J.3 - Telesis Bio Inc. (0001850079) (Issuer)
- SECCodex DNA Inc. filed SEC Form 8-K: Leadership Update8-K - Telesis Bio Inc. (0001850079) (Filer)
- SECCodex DNA Inc. filed SEC Form 8-K: Leadership Update8-K - Telesis Bio Inc. (0001850079) (Filer)
- SECCodex DNA Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits8-K - Telesis Bio Inc. (0001850079) (Filer)
- SECSEC Form 10-Q filed by Codex DNA Inc.10-Q - Telesis Bio Inc. (0001850079) (Filer)
- SECCodex DNA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Telesis Bio Inc. (0001850079) (Filer)
- SECSEC Form EFFECT filed by Codex DNA Inc.EFFECT - Telesis Bio Inc. (0001850079) (Filer)
- SECSEC Form S-3 filed by Codex DNA Inc.S-3 - Telesis Bio Inc. (0001850079) (Filer)
- SECCodex DNA Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Submission of Matters to a Vote of Security Holders8-K - Telesis Bio Inc. (0001850079) (Filer)
- 13D/GSEC Form SC 13G/A filed by Codex DNA Inc. (Amendment)SC 13G/A - Telesis Bio Inc. (0001850079) (Subject)
- 13D/GSEC Form SC 13G/A filed by Codex DNA Inc. (Amendment)SC 13G/A - Telesis Bio Inc. (0001850079) (Subject)
- SECSEC Form D filed by Codex DNA Inc.D - Telesis Bio Inc. (0001850079) (Filer)
- 13D/GSEC Form SC 13D filed by Codex DNA Inc.SC 13D - Telesis Bio Inc. (0001850079) (Subject)
- SECCodex DNA Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - Telesis Bio Inc. (0001850079) (Filer)
- INSIDERSEC Form 4 filed by Meister Paul M4 - Telesis Bio Inc. (0001850079) (Issuer)
- INSIDERSEC Form 3 filed by new insider Novalis Lifesciences Investments Ii Gp, Llc3 - Telesis Bio Inc. (0001850079) (Issuer)
- INSIDERSEC Form 4 filed by Northpond Ventures Gp, Llc4 - Telesis Bio Inc. (0001850079) (Issuer)
- 13D/GSEC Form SC 13D/A filed by Codex DNA Inc. (Amendment)SC 13D/A - Telesis Bio Inc. (0001850079) (Subject)
DNAY FAQ
7 questionsWhat does Codex DNA Inc. do?
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly...Where does DNAY stock trade?
Codex DNA Inc. (DNAY) is listed on NASDAQ.What sector and industry is DNAY in?
Codex DNA Inc. operates in the Health Care sector, Medical Specialities industry.When did Codex DNA Inc. go public?
Codex DNA Inc. (DNAY) completed its IPO in 2021.What are analysts saying about DNAY?
Codex DNA Inc. has had 5 recent analyst actions on file. The most recent action was from Cowen: Outperform on 2022-03-02. Recent price targets range from $2300.00 to $3000.00.What companies are similar to DNAY?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), HUM (Humana Inc.). Compare DNAY side-by-side with any of them on Quantisnow.How can I track DNAY on Quantisnow?
Quantisnow aggregates Codex DNA Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow DNAY to receive live email and push alerts on every new disclosure.